| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/18/2001 | EP1115847A1 Short peptides which selectively modulate the activity of protein kinases |
| 07/18/2001 | EP1115845A2 Fibrils |
| 07/18/2001 | EP1115747A1 Polymer complexes of glucuronoglucanes |
| 07/18/2001 | EP1115746A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 07/18/2001 | EP1115735A1 31 human secreted proteins |
| 07/18/2001 | EP1115733A1 Sequences characteristic of hypoxia-regulated gene transcription |
| 07/18/2001 | EP1115720A2 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/18/2001 | EP1115719A2 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 07/18/2001 | EP1115716A1 2-phenylpyran-4-one derivatives |
| 07/18/2001 | EP1115712A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 07/18/2001 | EP1115707A1 Benzamide derivatives and ther use as cytokine inhibitors |
| 07/18/2001 | EP1115704A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
| 07/18/2001 | EP1115701A1 Arylsulfonanilide ureas |
| 07/18/2001 | EP1115687A1 5,6-dihydronaphthalenyl derivatives having retinoid-like activity |
| 07/18/2001 | EP1115427A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 07/18/2001 | EP1115426A1 Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers and testicular cancer |
| 07/18/2001 | EP1115418A2 Aglyco products and methods of use |
| 07/18/2001 | EP1115412A1 Neuroimmunophilins for selective neuronal radioprotection |
| 07/18/2001 | EP1115411A1 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 07/18/2001 | EP1115402A1 Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas |
| 07/18/2001 | EP1115398A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/18/2001 | EP1115397A1 Method of mitigating the adverse effects of interleukin-2 |
| 07/18/2001 | EP1115396A1 Pharmaceutically active compounds and methods of use thereof |
| 07/18/2001 | EP1115395A1 ACTIVE ENANTIOMER OF RARgamma-SPECIFIC AGONIST |
| 07/18/2001 | EP1115391A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 07/18/2001 | EP1033369A4 5H-PYRANO [2,3-d:6,5-d']DIPYRIMIDINE DERIVATIVES HAVING AN ANTIBACTERIAL, ANTIVIRAL AND IMMUNO-MODULATING ACTIVITY |
| 07/18/2001 | EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists |
| 07/18/2001 | EP0846170B1 Modified protein kinase a-specific oligonucleotides and methods of their use |
| 07/18/2001 | EP0793667B1 Trinuclear cationic platinum complexes having antitumour activity and pharmaceutical compositions containing them |
| 07/18/2001 | EP0713870B1 Novel fused indan derivative and pharmaceutically acceptable salt thereof |
| 07/18/2001 | EP0667787B1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines |
| 07/18/2001 | CN1304453A Vaccine-induced hepatitis B viral strain and uses thereof |
| 07/18/2001 | CN1304442A Delivery of proteins into eukaryotic cells with recombinant Yersinia |
| 07/18/2001 | CN1304406A Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/18/2001 | CN1304311A Bridged indenopyrrolocarbazoles |
| 07/18/2001 | CN1304309A Semi-synthetic ecteinascidins |
| 07/18/2001 | CN1304306A Method for inhibiting MRP1 |
| 07/18/2001 | CN1303930A Novel polypeptide-zinc finger protein 57 and polynucleotide coding said polypeptide |
| 07/18/2001 | CN1303867A New tumor inhibitor |
| 07/18/2001 | CN1303866A Novel polypeptide-zinc finger protein 36 and polynucleotide for coding this polypeptide |
| 07/18/2001 | CN1303864A Novel polypeptide-zinc finger protein 60 and polynucleotide for coding said polypeptide |
| 07/18/2001 | CN1303859A Carbazole derivatives their preparing process and pharmaceutical composition containing them |
| 07/18/2001 | CN1303712A Mixed medicine for resisting cancer |
| 07/18/2001 | CN1303708A Chinese patent medicine for curing acute leukemia and its preparation process |
| 07/18/2001 | CN1303697A Pain-stopping medicine for external application for curing cancers |
| 07/18/2001 | CN1068587C Ortho-substituted benzoic acid derivatives |
| 07/18/2001 | CN1068523C Medicine for curing cancer and its preparing technology |
| 07/18/2001 | CN1068522C Chinese medicine preparation for curing cancer and its compounding method |
| 07/18/2001 | CN1068520C Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 07/18/2001 | CN1068517C Use of 2(3) tertiary butyl-4-hydroxy-anisole in preparation of drug for preventing and curing tissue organ traumatic disease |
| 07/17/2001 | US6262316 Administering a xanthophylles |
| 07/17/2001 | US6262271 ISO-CBI and ISO-CI analogs of CC-1065 and the duocarmycins |
| 07/17/2001 | US6262267 Has gonadotropin-releasing hormone antagonizing activity; useful for preventing or treating sex hormone-dependent diseases, e,g., sex hormone-dependent cancers e.g., prostatic cancer, uterine cancer, breast cancer, pituitary tumor |
| 07/17/2001 | US6262247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/17/2001 | US6262244 Genes coding for the extracellular part of four specific nkg2 (natural killer) transmembrane proteins; useful in treating infectious diseases and cancer |
| 07/17/2001 | US6262242 Tumor suppressor designated TS10Q23.3 |
| 07/17/2001 | US6262123 Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament comprising them |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/17/2001 | US6262110 Farnesyl-protein transferase inhibitors |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262094 Anticancer or cytotoxic agent |
| 07/17/2001 | US6262088 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262054 Combination therapy method for treating breast cancer using edatrexate |
| 07/17/2001 | US6262053 Effective for treating tumor cells and particularly effective to induce apoptosis in leukemia and breast tumor cells. |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262032 Method of destroying hyperproliferative cells by combined p53 and taxoid treatment |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6261840 Nucleotide sequences for gene expression inhibition of protein phosphatase 1b, a protein tyrosine phosphatase; diagnosis and antisense therapy of related diseases |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261831 Parallel plate transmission line apparatus for use in electroporosis treatment |
| 07/17/2001 | US6261818 Nucleotide sequence of cardiac-related ankyrin-repeat protein kinase; antisense agents; probes; primers; vectors; host cells; antibodies; diagnosis and treatment of cardiovascular disorders |
| 07/17/2001 | US6261801 Nucleic acids encoding tumor necrosis factor receptor 5 |
| 07/17/2001 | US6261791 Method for diagnosing cancer using specific PSCA antibodies |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261562 Compounds for immunotherapy of prostate cancer and methods for their use |
| 07/17/2001 | US6261555 Reovirus for the treatment of neoplasia |
| 07/17/2001 | US6261548 Polypeptides for leukemia inhibitor factors with amino acid sequences |
| 07/17/2001 | US6261535 Images of tumors |
| 07/17/2001 | CA2331167A1 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/17/2001 | CA2261500C Stable oxaliplatin solutions and their use in cytostatic antineoplastic treatment |
| 07/17/2001 | CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them |
| 07/17/2001 | CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances |
| 07/17/2001 | CA2126911C Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 |
| 07/17/2001 | CA2126910C Isolation and structure of spongistatins 5, 7, 8, and 9 |
| 07/17/2001 | CA2119363C 10-desacetoxytaxol derivatives |
| 07/12/2001 | WO2001049885A1 EGS MOLECULES THAT SPECIFICALLY DOWNREGULATE bcl-xL EXPRESSION |
| 07/12/2001 | WO2001049866A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins |
| 07/12/2001 | WO2001049851A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | WO2001049825A1 Methods for protein transfer |
| 07/12/2001 | WO2001049743A2 Methods of modulation of the immune system |
| 07/12/2001 | WO2001049740A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | WO2001049739A1 A new polypeptide-myelin p0 protein 14 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049736A1 A new polypeptide-human rs3 protein and the polynucleotide encoding it |
| 07/12/2001 | WO2001049731A1 A new polypeptide-human protease regulatory protein 9 and the polynucleotide encoding it |
| 07/12/2001 | WO2001049717A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity |
| 07/12/2001 | WO2001049715A2 Methods and compositions for inhibiting neoplastic cell growth |